| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel
1 company
Liptak Vincent Paul serves as a General Counsel at BLSM. Across recent SEC filings that breaks down to 2 buys and 0 sells. Those positions are worth an estimated $363K at current prices.
The biggest single holding is BLSM (~$363K) as General Counsel. Net of sales, the recent Form 4 record there shows accumulation of 4,700 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | BLSM Blossomhill Therapeutics, Inc. Common Stock | General Counsel | Buy | 4,700 | $15.89 | $74,700.00 | +4.4% |